as 03-31-2025 10:39am EST
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | WARSAW |
Market Cap: | 601.5M | IPO Year: | 2017 |
Target Price: | $37.33 | AVG Volume (30 days): | 190.5K |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.64 | EPS Growth: | N/A |
52 Week Low/High: | $21.02 - $35.99 | Next Earning Date: | 03-04-2025 |
Revenue: | $204,727,000 | Revenue Growth: | 37.65% |
Revenue Growth (this year): | 19.47% | Revenue Growth (next year): | 17.14% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Bailey David R | KIDS | President and CEO | Mar 15 '25 | Sell | $24.86 | 6,620 | $164,573.20 | 319,155 | |
Hite Fred | KIDS | COO and CFO | Mar 15 '25 | Sell | $24.86 | 6,443 | $160,172.98 | 207,989 | |
Odle Gregory A | KIDS | President of Scoliosis | Mar 15 '25 | Sell | $24.86 | 5,359 | $133,224.74 | 148,788 | |
Gerritzen Daniel J | KIDS | General Counsel and Secretary | Mar 15 '25 | Sell | $24.86 | 5,310 | $132,006.60 | 110,767 | |
Hauser Joseph W | KIDS | Pres. Trauma & Def. Correction | Mar 15 '25 | Sell | $24.86 | 5,300 | $131,758.00 | 137,663 |
KIDS Breaking Stock News: Dive into KIDS Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
GlobeNewswire
7 days ago
GlobeNewswire
14 days ago
Simply Wall St.
23 days ago
GuruFocus.com
a month ago
Zacks
a month ago
MT Newswires
a month ago
Zacks
a month ago
The information presented on this page, "KIDS OrthoPediatrics Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.